2017

    • Nevalan®, a drug for acid related disorders, Entevirem®, an antiviral for systemic use, Rezavir®, an antiviral for systemic use, and Bradirem®, a cardiac therapy were registered successfully in Cyprus.
    • Remedica elected as the best Company in the Ascendis Health Group of Companies
    • Co-founded CSR Cyprus